The Heart Failure Policy Network

arrow-splash

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from Novartis Pharma and Vifor Pharma. Additional support for The handbook launch in September 2018 has been provided by Bayer AG. The content produced by the Network is not biased to any specific treatment or therapy, and is endorsed and owned by the Network’s members, who have full editorial control. All members provide their time for free.

Huge thanks to the 94 candidates who have signed the #HFpledge so far including a new pledge from Spain @fgambus_eu 1 in 5 of us can expect to develop the condition at some point in our lives and it's vital we improve the quality of #HFcare. bit.ly/HF_pledge pic.twitter.com/dLd5CWGv6j